Dr Paul Liknaitzky is head of the Clinical Psychedelic Lab, and Senior Research Fellow within the Dept of Psychiatry at Monash University. He has played a central role in establishing the field of clinical psychedelic research in Australia, is the Principal Investigator on a program of psychedelic trials, and is the Director of the Monash Psychedelic Education Program. Liknaitzky leads the country’s largest and most experienced group of psychedelic researchers and clinicians, and collaborates with numerous psychedelic groups nationally and internationally. Liknaitzky’s work is focused on investigating novel applications for psychedelic therapies, translating evidence into best clinical practice, exploring under-examined risks, delivering next-generation therapist training, and improving access and affordability.